AMP has announced that it would maintain AXA North and AMP Flexible Super as part of its product and platform plans for the AXA/AMP merger.
AMP’s SignatureSuper would be its medium and large corporate superannuation product, while AMP Flexible Super would target small to medium businesses, the group added.
AMP would continue to invest in its two distinctive insurance offerings — AMP’s Flexible Lifetime Protection and AXA’s Elevate — to ensure they remained competitive, AMP stated. However, within the next two years the company would build a new retail insurance product range that would take the best attributes of the two current offerings.
AMP and AXA’s group risk products would remain, while the group aimed to enhance AMP’s group risk offer that supported AMP’s mastertrust superannuation product and invest in AXA’s stand-alone offer to capitalise on profitable growth opportunities.
The lower outlook for inflation has set the stage for another two rate cuts over the first half of 2026, according to Westpac.
With private asset valuations emerging as a key concern for both regulators and the broader market, Apollo Global Management has called on the corporate regulator to issue clear principles on valuation practices, including guidance on the disclosures it expects from market participants.
Institutional asset owners are largely rethinking their exposure to the US, with private markets increasingly being viewed as a strategic investment allocation, new research has shown.
Australia’s corporate regulator has been told it must quickly modernise its oversight of private markets, after being caught off guard by the complexity, size, and opacity of the asset class now dominating institutional portfolios.